Use of a bisphosphonate in the preparation of a medicament for the
treatment of osteoporosis post hip fracture to prevent or reduce
subsequent osteoporotic skeletal fractures in a patient in need of such
treatment, and particularly to a patient who has undergone recent repair
of the hip fracture and corresponding methods of treatment.